BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15220821)

  • 1. Practical markers used in the diagnosis of endocrine tumors.
    Erickson LA; Lloyd RV
    Adv Anat Pathol; 2004 Jul; 11(4):175-89. PubMed ID: 15220821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical markers used in the diagnosis of neuroendocrine tumors.
    Lloyd RV
    Endocr Pathol; 2003; 14(4):293-301. PubMed ID: 14739487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
    Kasprzak A; Zabel M; Biczysko W
    Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical Staining With Neuroendocrine Markers is Essential in the Diagnosis of Neuroendocrine Neoplasms of the Esophagogastric Junction.
    Jepsen DNM; Fiehn AK; Garbyal RS; Engel U; Holm J; Federspiel B
    Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):454-461. PubMed ID: 33480601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synaptic vesicle protein 2, A new neuroendocrine cell marker.
    Portela-Gomes GM; Lukinius A; Grimelius L
    Am J Pathol; 2000 Oct; 157(4):1299-309. PubMed ID: 11021834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors.
    Rosa P; Gerdes HH
    J Endocrinol Invest; 1994 Mar; 17(3):207-25. PubMed ID: 8051343
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum chromogranin A in the diagnosis and follow-up of neuroendocrine tumors of the gastroenteropancreatic tract.
    Schürmann G; Raeth U; Wiedenmann B; Buhr H; Herfarth C
    World J Surg; 1992; 16(4):697-701; discussion 701-2. PubMed ID: 1413839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granin-derived peptides as diagnostic and prognostic markers for endocrine tumors.
    Conlon JM
    Regul Pept; 2010 Nov; 165(1):5-11. PubMed ID: 19931574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chromogranin A: a marker of neuroendocrine tumors].
    D'Herbomez M; Gouze V
    Ann Biol Clin (Paris); 2002; 60(6):641-6. PubMed ID: 12446227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endocrine tumor].
    Sasano H
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):121-4. PubMed ID: 15675597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical localization of chromogranin A in endocrine tissues and endocrine tumors of dogs.
    Doss JC; Gröne A; Capen CC; Rosol TJ
    Vet Pathol; 1998 Jul; 35(4):312-5. PubMed ID: 9684978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor markers in neuroendocrine tumors.
    Eriksson B; Oberg K; Stridsberg M
    Digestion; 2000; 62 Suppl 1():33-8. PubMed ID: 10940685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine needle aspiration cytology of primary neuroendocrine tumor of the breast and it's differential diagnosis.
    Trivedi S; Dixit N; Suri M
    Diagn Cytopathol; 2021 Jan; 49(1):171-175. PubMed ID: 33048455
    [No Abstract]   [Full Text] [Related]  

  • 14. Synaptophysin and chromogranins/secretogranins--widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis.
    Wiedenmann B; Huttner WB
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 58(2):95-121. PubMed ID: 2575822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumors of the endocrine/neuroendocrine system: an overview.
    Erlandson RA; Nesland JM
    Ultrastruct Pathol; 1994; 18(1-2):149-70. PubMed ID: 7910711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.
    Uccella S; La Rosa S; Volante M; Papotti M
    Endocr Pathol; 2018 Jun; 29(2):150-168. PubMed ID: 29520563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity.
    Chernyavsky VS; Farghani S; Davidov T; Ma L; Barnard N; Amorosa LF; Trooskin SZ
    Thyroid; 2011 Feb; 21(2):193-6. PubMed ID: 21275766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability of commercially available immunocytochemical markers for identification of neuroendocrine differentiation in bronchoscopic biopsies of bronchial carcinoma.
    Gosney JR; Gosney MA; Lye M; Butt SA
    Thorax; 1995 Feb; 50(2):116-20. PubMed ID: 7701447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 34betaE12 cytokeratin immunodetection in the differential diagnosis of neuroendocrine carcinomas of the breast.
    Papotti M; Sapino A; Righi L; Chiappone S; Bussolati G
    Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):229-33. PubMed ID: 11556750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia.
    Feldman SA; Eiden LE
    Endocr Pathol; 2003; 14(1):3-23. PubMed ID: 12746559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.